Skip to main content
. 2020 Apr 20;12(1):1746520. doi: 10.1080/19420862.2020.1746520

Table 3.

Biodistribution study design incorporating both non-residualizing (125I) and residualizing (111In) radio-tracers for M616 for quantitation.

Group (n = 24) Total M616 Dose (mg/kg) Tracer (% of M616 Material Labeled) Route# Tissues Sampled
1 0.3 125I (100) IV Whole-blood, heart, liver, lung, kidney, spleen, thymus, brain, skin (middle between shoulders), muscle, femur, lymph nodes
2 10 125I (3) IV
3 0.3 111In (100) IV
4 10 111In (3) IV

# Time Points: 0.5, 2, 4, 12, 24, 48, 96, 120 h.